𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative correlation between 1H MRS and dynamic contrast-enhanced MRI of human breast cancer

✍ Scribed by Hyeon-Man Baek; Hon J. Yu; Jeon-Hor Chen; Orhan Nalcioglu; Min-Ying Su


Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
578 KB
Volume
26
Category
Article
ISSN
0730-725X

No coin nor oath required. For personal study only.

✦ Synopsis


Proton magnetic resonance spectroscopy ( 1 H MRS) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) provide functional information, including vascular volume, vascular permeability and choline (Cho) metabolism. In this study, we applied these two imaging modalities to quantitatively characterize 36 malignant breast lesions in 32 patients and analyzed the correlation between them. Cho concentration was quantified by single-voxel 1 H MRS using water as an internal reference. The measured Cho levels ranged from 0.32 to 10.47 mmol/kg, consistent with previously reported values. In 25 mass-type lesions, the Cho concentration was significantly correlated with tumor size (r = .69, Pb.0002). In addition, the Cho level was found to be significantly higher in lesions presenting as mass-type lesions compared to non-mass-type diffuse enhancements (P = .035). The enhancement kinetics from tissues covered within each MRS voxel were measured and analyzed with a two-compartmental model to obtain pharmacokinetic parameters K trans and k ep . A significant correlation was found between the Cho level and the pharmacokinetic parameter k ep (r = .62, Pb.0001), indicating that tissues with a high Cho level have higher wash-out rates in DCE MRI. The results suggest a correlation between Cho metabolism and angiogenesis activity, which might be explained by the association of Cho with cell replication and angiogenesis required to support tumor growth.


📜 SIMILAR VOLUMES


Combined quantitative dynamic contrast-e
✍ Ferdinand A. van Dorsten; Marinette van der Graaf; Marc R.W. Engelbrecht; Geert 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

## Purpose: To differentiate prostate carcinoma from healthy peripheral zone and central gland using quantitative dynamic contrast-enhanced (dce) magnetic resonance (mr) imaging and two-dimensional (1)h mr spectroscopic imaging (mrsi) combined into one clinical protocol. ## Materials and methods:

Dynamic contrast-enhanced MRI of primary
✍ Jing Gu; Pek-Lan Khong; Silun Wang; Queenie Chan; Ed X. Wu; Wailun Law; Rico Kin 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB

## Abstract ## Purpose To assess the correlations between parameters measured on dynamic contrast‐enhanced magnetic resonance imaging and 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET) in rectal cancer. ## Materials and Methods To assess the correlations between parameters measure

Comparison of quantitative parameters in
✍ Cheng Yang; Walter M. Stadler; Gregory S. Karczmar; Michael Milosevic; Ivan Yeun 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

## Abstract Cervical tumors of 38 cervix cancer patients were scanned by __T__~1~‐weighted dynamic contrast enhanced (DCE) MRI and then by DCE‐CT on the same day. Gadodiamide and iohexol were respectively used as the low‐molecular‐weight contrast agent in DCE‐MRI and DCE‐CT. Under an extended Tofts

Reproducibility of dynamic contrast-enha
✍ Susan M. Galbraith; Martin A. Lodge; N. Jane Taylor; Gordon J. S. Rustin; Søren 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

## Abstract The purpose of this study was to determine the reproducibility of dynamic contrast‐enhanced (DCE)‐MRI and compare quantitative kinetic parameters with semi‐quantitative methods, and whole region‐of‐interest (ROI) with pixel analysis. Twenty‐one patients with a range of tumour types unde

Association between serial dynamic contr
✍ Savannah C. Partridge; Risa K. Vanantwerp; Robert K. Doot; Xiaoyu Chai; Brenda F 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

## Abstract ## Purpose To investigate the relationship between changes in vascularity and metabolic activity measured by dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) and dynamic ^18^F‐FDG‐positron emission tomography (PET) in breast tumors undergoing neoadjuvant chemotherapy. ##